| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.9M | +49.6% |
| R&D Expense | $45.1M | -37.2% |
| SG&A Expense | $30.1M | -25.8% |
| Operating Income | -$43.9M | +49.2% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$77.1M | +67.7% |
| Income Tax | $287K | +101.5% |
| Net Income | -$77.4M | +64.8% |
| EPS (Basic) | -$4.48 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $212.6M | +176.4% |
| Accounts Receivable | $872K | -85.1% |
| Current Assets | $216.6M | +138.8% |
| Total Assets | $435.0M | +42.6% |
| Current Liabilities | $23.0M | -66.3% |
| Total Liabilities | $441.8M | -0.6% |
| Stockholders' Equity | -$6.8M | +98.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.7M | +53.7% |
| Capital Expenditures | $9.1M | +4314.1% |
| Investing Cash Flow | -$8.7M | -125.3% |
| Financing Cash Flow | $168.4M | +1381.3% |
| Free Cash Flow | -$32.8M | +36.2% |
| -169.9% |
| EPS (Diluted) | -$4.49 | -170.5% |